54741_Image_jpeg.jpg
New Research Further Demonstrates Clinical Superiority of Daxor Corporation’s Blood Volume Analyzer (BVA-100®) in Critical Care
February 20, 2020 08:30 ET | Daxor Corporation
NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
54741_Image_jpeg.jpg
Newly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Hypertension
September 24, 2019 08:00 ET | Daxor Corporation
NEW YORK, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
54741_Image_jpeg.jpg
Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice
May 30, 2019 08:00 ET | Daxor Corporation
NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
54741_Image_jpeg.jpg
Daxor Corporation to Exhibit at the Society of Hospital Medicine (SHM) Annual Conference 2019
March 22, 2019 08:30 ET | Daxor Corporation
NEW YORK , March 22, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
54741_Image_jpeg.jpg
Daxor Corporation Announces Rise in Kit Sales and Files Form N-CSR For 2018
March 04, 2019 08:30 ET | Daxor Corporation
NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
54741_Image_jpeg.jpg
New Data Demonstrating the Clinical Utility of Daxor’s BVA-100 in Hypertension Management to be Presented at the American Heart Association’s Scientific Sessions 2018 
November 08, 2018 13:46 ET | Daxor Corporation
Daxor to Exhibit at American Heart Association 2018 NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation...
54741_Image_jpeg.jpg
Daxor Corporation Initiates Strategic Collaboration with CHF Solutions, Inc. to Manage Patients with Fluid Overload
November 01, 2018 08:30 ET | Daxor Corporation
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (NYSE MKT: DXR) announced today that it has entered into an agreement with CHF Solutions (Nasdaq: CHFS) to explore clinical synergies...
54741_Image_jpeg.jpg
Daxor Corporation Appoints Robert J. Michel as Chief Financial Officer
September 28, 2018 08:30 ET | Daxor Corporation
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
54741_Image_jpeg.jpg
Daxor Corporation to Present at The MicroCap Conference on October 2, 2018
September 25, 2018 08:30 ET | Daxor Corporation
NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an innovative medical instrumentation and biotechnology company focused on blood volume measurement, today announced...
54741_Image_jpeg.jpg
Daxor Corporation to Exhibit at the 22nd Annual Scientific Meeting of the Heart Failure Society of America
September 12, 2018 08:30 ET | Daxor Corporation
NEW YORK, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...